Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

Threads users have complained about its recommendation algorithm since the dawn of time 2023. Users even started writing posts addressed to the algorithm, specifying the topics they wanted to see more ...

Never miss a story with The Brief, our free newsletter. Independent Texas reporting needs your support. Help us bring you and millions of others in-depth news and information. Will you join our ...

RNA interference using small interfering RNAs (siRNAs) has become a mainstay of functional gene characterization and has generated over a dozen FDA-approved therapeutics and drugs in late-stage ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Six of the nation's biggest landlords are accused of using RealPage's algorithms to fix rent prices and harm renters. Some of those companies had units in the Las Vegas Valley. Under the agreement ...

The company isn't the only developer of a drug for FAP, a rare genetic disease. A rival just reported that its own FAP treatment is advancing to late-stage testing. 10 stocks we like better than ...

MAA Lakepointe, a Lexington apartment complex off Richmond Road, is owned by Mid-America Apartment Communities Inc. It’s one of the defendants in a lawsuit filed July 3, 2025, by Kentucky’s attorney ...

Amsterdam’s struggles with its welfare fraud algorithm show us the stakes of deploying AI in situations that directly affect human lives. What Amsterdam’s welfare fraud algorithm taught me about fair ...